Loftware acquires PRISYM ID

Loftware Inc., a software company specializing in enterprise labeling, has acquired PRISYM ID, a leading provider of regulated content and label management solutions with a focus on clinical trials, medical device and pharmaceutical labeling. The acquisition expands Loftware’s reach in the medical device and pharmaceutical industries. It also enhances the company’s end-to-end cloud-based labeling platform by adding advanced clinical trial labeling and regulated content management capabilities.

The need to improve agility, manufacturing, and distribution in support of patient safety and healthcare outcomes has never been more vital as COVID-19 has amplified the challenges in medical device and pharmaceutical supply chains. Building on PRISYM’s https://prisymid.com/ offerings, Loftware https://www.loftware.com/  will offer customers new levels of innovation to help enable compliance through accurate, validation-ready labeling solutions and regulated product content. The acquisition also builds on Loftware’s platform that empowers companies to optimize continuity, improve agility and enable traceability as they’re faced with new and ensuing challenges around today’s complex supply chain.

This acquisition will also help customers tackle the challenges of clinical trial labeling, performed either in-house, through clinical research organizations or through clinical development and manufacturing organizations. This comes at a time when companies are setting new benchmarks for accelerating clinical development and the need to decentralize clinical trials and deliver supplies to a myriad of locations.

“This acquisition builds on Loftware’s and PRISYM ID’s experience and unites the best talent in the medical device and pharmaceutical labeling industry today. Combined, we serve many of the largest global companies with solutions, services and support that are vital to managing labeling complexities and regulatory requirements,” stated Loftware President and CEO, Robert O’Connor Jr. “PRISYM ID is a pioneer in clinical trials labeling and delivers solutions that are purpose built for managing the nuances of this space. We will enable customers to tackle the complex challenges around clinical trial labeling and help them with the ability to quickly and efficiently complete trials,” he added.

“Together with Loftware, we can offer new levels of innovation which will further accelerate momentum in serving our customers and market. We’ll also be expanding our global presence and increasing our service and support resources to better serve our customers and meet increasing demands,” stated Richard Adams, CEO of PRISYM ID. “By combining the competences of two leaders in the field, we can provide unrivaled solutions for the medical device and pharmaceutical industries, unlock new opportunities in clinical trials labeling and offer a full range of solutions for customers to meet all their labeling needs,” he added.

SC
MR